[Editorial] Essential medicines for neurological disorders: updates, rejections, and the road ahead

Several updates relevant to neurologists and health-care professionals involved in the prevention and treatment of neurological diseases have been added to the WHO Model List of Essential Medicines (EML). The inclusion of drugs into “the world's most influential list of medicines” is a necessary step towards equitable access. WHO's aspiration is for most countries to have access to all essential medicines for neurological disorders by 2031, and more drugs need to be added to the list in upcoming revisions if this goal is to be fulfilled.